Characterization of P1 promoter activity of the beta-galactoside alpha2,6-sialyltransferase I gene (siat 1) in cervical and hepatic cancer cell lines.

Journal of Biosciences
Lorena Milflores-FloresVerónica Vallejo-Ruiz

Abstract

The level of beta-galactoside alpha2,6-sialyltransferase I (ST6Gal I) mRNA, encoded by the gene siat1, is increased in malignant tissues. Expression is regulated by different promoters - P1, P2 and P3 - generating three mRNA isoforms H, X and YZ. In cervical cancer tissue the mRNA isoform H, which results from P1 promoter activity, is increased. To study the regulation of P1 promoter, different constructs from P1 promoter were evaluated by luciferase assays in cervical and hepatic cell lines. Deletion of a fragment of 1048 bp (-89 to +24 bp) increased 5- and 3-fold the promoter activity in C33A and HepG2 cell lines, respectively. The minimal region with promoter activity was a 37 bp fragment in C33A cells. The activity of this region does not require the presence of an initiator sequence. In HepG2 cells the minimal promoter activity was detected in the 66 bp fragment. Sp1 (-32) mutation increased the promoter activity only in HepG2 cells. HNF1 mutation decreased promoter activity in HepG2 cell line but not in C33A cells. We identified a large region that plays a negative regulation role. The regulation of promoter activity is cell type specific. Our study provides new insights into the complex transcriptional regulation of sia...Continue Reading

References

Mar 22, 1991·Science·H KatoR G Roeder
Aug 1, 1990·The Journal of Experimental Medicine·I StamenkovicS Funderud
Apr 7, 1989·Cell·S T Smale, D Baltimore
Dec 11, 1994·Nucleic Acids Research·A Shrivastava, K Calame
May 17, 1996·The Journal of Biological Chemistry·B Manzano-WinklerA L Roy
Sep 1, 2001·Biochimie·A Harduin-LepersP Delannoy
Apr 22, 2003·Genes & Development·Natalie Rezai-ZadehEdward Seto
Jun 12, 2003·Gynecologic Oncology·Peng Hui WangChiou Chung Yuan
Jul 25, 2003·Biochemical and Biophysical Research Communications·Liming XuAkiyoshi Taniguchi
Jun 1, 1996·Clinical Molecular Pathology·F Dall'olio
Sep 12, 2006·The Journal of Biological Chemistry·Margaret Po-shan LukeYang Shi
Feb 18, 2011·Transcription·Zhiyong DengGuangchao Sui
Sep 13, 2011·Clinical Proteomics·Danni L Meany, Daniel W Chan

❮ Previous
Next ❯

Related Concepts

Related Feeds

Carcinoma, Hepatocellular

Hepatocellular Carcinoma is a malignant cancer in liver epithelial cells. Discover the latest research on Hepatocellular Carcinoma here.

Adrenocortical Carcinoma

Hepatocellular carcinoma is the most common type of primary liver cancer and frequently occurs in individuals with chronic liver diseases like cirrhosis. Here is the latest research.